|Articles|January 11, 2017

H3N2 Influenza Leads to More Severe Flu Cases Around the United States

Author(s)Einav Keet

The 2016-2017 influenza season continues to see a growing number of severe flu cases due to the increased prevalence of influenza A (H3N2) virus.

Influenza activity is now categorized as widespread in at least 12 states as the flu season continues to hit the United States, with some regions already experiencing epidemic-level outbreaks resulting in severe illness, a number of hospitalizations, and even deaths.

In its annual surveillance of flu season activity, the Centers for Disease Control and Prevention (CDC) categorizes the level of flu activity in each state as either sporadic, local, regional, or widespread. In a new influenza surveillance map detailing surveillance data for the 2016 -2017 flu season, the CDC has reported widespread virus activity in California, Connecticut, Idaho, Massachusetts, New Hampshire, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Virginia, and Washington. So far this season, public health laboratories around the country have collected 3,793 influenza positive specimens, of which 3,193 are influenza A (H3N2). Despite the slow start to this season, the predomination of this strain of the virus has led to more severe illnesses.

Officials from California’s Department of Public Health (CDPH) have reported that widespread flu activity in the state has led to at least three influenza-related deaths and 29 severe cases of infection that resulted in patients under 65 years of age being hospitalized. Laboratories in the state have collected at least 1,488 specimens that tested positive for the flu, and CDPH officials noted that the specimens closely match the components of the 2016-2017 flu vaccine. The San Francisco Health Department is reminding local residents who have not yet received the influenza vaccination, that it’s not too late to receive a flu shot; this warning comes on the heels of a widespread flu outbreak that led to three deaths in the Bay Area.

In Washington state, health department officials have reported 24 lab-confirmed influenza deaths so far this flu season, as the Pacific Northwest continues to be hit hard by the epidemic. The CDC’s weekly FluView report noted that Region 10—which includes Washington, Oregon, and Alaska—has the country’s highest rate of respiratory specimens having tested positive for the flu, with 27.4% of all specimens now flu-positive versus a low of 5.5% of specimens in Region 5. Influenza A (H3N2) and influenza A viruses that have not been subtyped have been most prevalent in the state, according to laboratory results from World Health Organization/National Respiratory and Enteric Virus Surveillance System (WHO/NREVSS). Washington’s Snohomish and Walla Walla counties as well as the Puget Sound region are just some of the areas that have reported a spike in flu-related hospitalizations and deaths.

On the East Coast, New York State’s Department of Health surveillance reported 2,784 laboratory-confirmed influenza reports and 845 patients hospitalized with the flu for the week ending December 31, 2016. Across the state, flu-related hospitalizations grew by 186% over the previous week, but there have been no cases of pediatric influenza-associated deaths.

With flu activity now at its peak, state officials are urging residents to receive the seasonal flu vaccine in order to prevent further spread of the virus, as the flu season can last as late as May.


Related to this article

REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.